PARP1 and cancer: While the addition of ADPr and PAR is critical for normal cellular health, it creates a therapeutic vulnerability in cancer patients with BRCA1/2 mutations and homologous-recombination deficiencies, because DNA repair broadly relies on PARP-dependent processes.